Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-01

Clinical Trial Update: Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia [Phase 4]

View source ↗

Summary

A Phase 4 trial sponsored by the University of Michigan is evaluating the effect of topical imiquimod on sebaceous hyperplasia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod (imiquimod)

Snippet

Sponsor: University of Michigan | Conditions: Sebaceous Hyperplasia | Phase 4 | Status: RECRUITING